Literature DB >> 19306979

Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy.

Mawash Babar1, Darren Ennis, Mohamed Abdel-Latif, Patrick J Byrne, Narayanasamy Ravi, John V Reynolds.   

Abstract

BACKGROUND: The Barrett's to adenocarcinoma sequence is characterized by molecular changes including activation of nuclear factor-kappaB (NF-kappaB) and related cytokines. In this observational nonrandomized study this molecular environment was compared in matched asymptomatic cohorts who had undergone either fundoplication or therapy with proton pump inhibitors (PPIs).
METHODS: Asymptomatic patients with long-segment Barrett's esophagus had endoscopic biopsy specimens taken from 2 cm below the squamocolumnar junction for measurement of activated NF-kappaB and a panel of cytokines and growth factors.
RESULTS: Thirty-seven patients were recruited (surgical: n = 18, medical: n = 19). The mean patient age was 51 years, and the mean follow-up period was 5.6 years. There were no differences in the length of Barrett's segment and endoscopic and histopathologic features in both groups. Mean activated NF-kappaB p50 and p65 subunits, interleukin (IL)-1alpha, IL-1beta, and interleukin-8 levels, were significantly (P < .05) lower in the surgically treated group.
CONCLUSIONS: This study provides proxy support to the thesis that antireflux surgery may provide an environment that is less inflammatory and tumorigenic than that observed in medically treated patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19306979     DOI: 10.1016/j.amjsurg.2008.11.032

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

Review 1.  Surgical treatment of GERD: systematic review and meta-analysis.

Authors:  Sophia K McKinley; Rebecca C Dirks; Danielle Walsh; Celeste Hollands; Lauren E Arthur; Noe Rodriguez; Joyce Jhang; Ahmed Abou-Setta; Aurora Pryor; Dimitrios Stefanidis; Bethany J Slater
Journal:  Surg Endosc       Date:  2021-03-02       Impact factor: 4.584

2.  Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus.

Authors:  Joerg Zehetner; Steven R DeMeester; Shahin Ayazi; Jesse L Costales; Florian Augustin; Arzu Oezcelik; John C Lipham; Helen J Sohn; Jeffrey A Hagen; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

3.  MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux.

Authors:  Sebastien Haiart; David I Watson; Mary P Leong; David Astill; Tim Bright; Damian J Hussey
Journal:  BMC Res Notes       Date:  2011-02-27

Review 4.  Antireflux surgery for dysplastic Barrett.

Authors:  Marco E Allaix; Marco G Patti
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.